Hyperbaric Oxygen Therapy as a Neuroprotective Intervention in Pediatric Acquired Brain Injury With Cognitive Disability
1 other identifier
interventional
120
1 country
1
Brief Summary
This research aimed to investigate the effectiveness of hyperbaric oxygen therapy as a neuroprotective strategy for improving neurological outcomes in pediatric patients who have sustained acquired brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 24, 2025
CompletedFirst Posted
Study publicly available on registry
May 1, 2025
CompletedMay 1, 2025
April 1, 2025
7 months
April 24, 2025
April 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Communication Function Classification System
The Communication Function Classification System (CFCS) was implemented to assess cognitive and speech capabilities across five levels of communicative competence. * Level I: Effective bidirectional communication (no need for external aids). * Level II: Consistent communication with familiar partners, occasional need for aids. * Level III: Communication requires significant effort and aids with familiar partners. * Level IV: Minimal communication, even with familiar partners. * Level V: No effective communication.
Eight months post-intervention
Secondary Outcomes (2)
Nutritional intake functionality
Eight months post-intervention
Visual function assessment
Eight months post-intervention
Study Arms (2)
Hyperbaric oxygen therapy group
EXPERIMENTALPatients received hyperbaric oxygen therapy (HBOT) using a monochamber hyperbaric chamber in addition to conventional rehabilitation.
Control group
ACTIVE COMPARATORPatients received conventional rehabilitation alone.
Interventions
Patients received hyperbaric oxygen therapy (HBOT) using a monochamber hyperbaric chamber in addition to conventional rehabilitation.
Eligibility Criteria
You may qualify if:
- Pediatric patients aged 4-12 years with acquired brain injury.
- Confirmed neurological sequelae (e.g., cardiac arrest, intracranial hemorrhage, central nervous system infections, stroke, tumor, hypoxia) via MRI/neurological exam.
You may not qualify if:
- Positive family history of degenerative brain insults.
- Behavioral problems.
- Hyperbaric oxygen therapy contraindications:
- Active epilepsy.
- Respiratory insufficiency.
- Uncontrolled heart failure.
- Eustachian tube dysfunction.
- Tympanic membrane rupture.
- Mechanical ventilation dependency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kafrelsheikh University
Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of Pediatrics, Faculty of Medicine, Kafr Elsheikh University, Kafr Elsheikh, Egypt.
Study Record Dates
First Submitted
April 24, 2025
First Posted
May 1, 2025
Study Start
March 1, 2024
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.